Who
Keith Humphreys
Director
Company insider
Files Form 4 as: Director, Indivior Pharmaceuticals.
In numbers
- Trades disclosed
- 6
- Buys
- 1
- Sells
- 0
- Bought
- $55K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 5 Jan 2026
- Last trade
- 13 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Jan – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,518 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,518 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,722 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,722 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $27K775 at $35.39 | filing |
| 5 Jan 2026filed 7 Jan 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $27K775 at $35.39 | filing |
News
Contrasting Orion OYJ (OTCMKTS:ORINY) & Indivior (NASDAQ:INDV)INDV · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Keith Humphreys; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.